David T.
About David T.
David T. is an Investment Banking Analyst at Jefferies in New York, with a background in private equity and investment banking, and a Bachelor's degree in Economics and Computer Science from Vanderbilt University.
Current Position at Jefferies
David T. is currently employed as an Investment Banking Analyst at Jefferies. Since 2023, he has been based in New York, New York, United States. His work involves significant financial transactions including mergers, acquisitions, and other investment banking activities.
Previous Roles in Investment Banking
David worked as an Investment Banking Summer Analyst at Jefferies in 2022 for three months. Before that, he interned at M.M. Dillon & Co. as an Investment Banking Summer Analyst in 2021, focusing on private financings for life sciences companies undergoing FDA trials. These roles equipped him with considerable experience in the investment banking sector.
Private Equity Experience
In 2020, David held a position as a Private Equity Summer Analyst at DVG Partners for five months. Based in the New York City Metropolitan Area, he was involved in analyzing private equity transactions, assessing investment opportunities, and conducting financial due diligence.
Entrepreneurial Ventures
David co-founded Camelot and served as its Chief Financial Officer from 2020 to 2021 in Nashville, Tennessee. Earlier, he was the Co-Founder and Chief Operating Officer of Optic Technologies from 2017 to 2019 at the Massachusetts Institute of Technology. These roles involved financial oversight, operational management, and strategic planning.
Educational Background
David earned his Bachelor's degree in Economics and Computer Science from Vanderbilt University, studying there from 2019 to 2023. He also attended Weston High School from 2015 to 2019. His education provided a strong foundation in both analytical skills and technical knowledge.
Notable Transactions and Contributions
While working at Jefferies, David contributed to high-profile transactions including the $1.4 billion sale of VetPartners to BPEA EQT, Azenta's $500 million acquisition of B Medical Systems, and the sale of Enzo Biochem to Labcorp. He also played a role in Structure Therapeutics's $300 million PIPE transaction.
Roles in Vanderbilt Investment Club
David was the Healthcare Portfolio Manager at the Vanderbilt Investment Club from 2019 to 2023 in Nashville, Tennessee. His tenure involved managing healthcare investments and making strategic portfolio decisions.